Mapping and predicting mortality from systemic sclerosis

Annals of the Rheumatic Diseases

DOI: 10.1136/annrheumdis-2017-211448 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 26 stored of 693

Information preferences about treatment options in diffuse cutaneous systemic sclerosis: A Delphi consensus study
2021 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access

2

citations
A randomised, open-label trial to assess the optimal treatment strategy in early diffuse cutaneous systemic sclerosis: the UPSIDE study protocol
2021 BMJ Open article Medicine Systemic Sclerosis and Related Diseases Open access

31

citations
From “being at war” to “getting back on your feet”: A qualitative study on experiences of patients with systemic sclerosis treated with hematopoietic stem cell transplantation
2020 Journal of Scleroderma and Related Disorders article Medicine Systemic Sclerosis and Related Diseases Open access

9

citations
Predictive factors for treatment-related mortality and major adverse events after autologous haematopoietic stem cell transplantation for systemic sclerosis: results of a long-term follow-up multicentre study
2020 Annals of the Rheumatic Diseases article Medicine Systemic Sclerosis and Related Diseases Open access cited by 1 patent

56

citations
Illness perceptions, risk perceptions and worries in patients with early systemic sclerosis: A focus group study
2020 Musculoskeletal Care article Medicine Systemic Sclerosis and Related Diseases Open access

6

citations
Autologous stem cell transplantation for progressive systemic sclerosis: a prospective non-interventional study from the European Society for Blood and Marrow Transplantation Autoimmune Disease Working Party
2020 Haematologica article Medicine Systemic Sclerosis and Related Diseases Open access cited by 2 patents

124

citations

Mapping and predicting mortality from systemic sclerosis

Authors 0

Cited by 26 stored of 693

References 0